BioStock Feed

2025-10-31 11:43:00 SynAct advances pipeline and extends runway to 2027

2025-10-31 11:43:00 SynAct stärker pipeline och förlänger finansieringen till 2027

2025-10-31 10:41:00 OncoZenge gearing up for phase III after a strong quarter

2025-10-31 10:41:00 OncoZenge rustar för fas III efter starkt kvartal

2025-10-31 08:02:00 Spago: "We are really encouraged by how the trial is progressing"

2025-10-31 08:02:00 Spago:”We are really encouraged by how the trial is progressing”

2025-10-30 15:19:00 Recruitment in full swing for Curasight's prostate cancer study

2025-10-30 15:19:00 Rekrytering i full gång till Curasights prostatacancerstudie

2025-10-30 09:55:00 BioInvent sharpens focus on its top clinical candidates

2025-10-30 09:55:00 BioInvent skärper fokus på de kliniska toppkandidaterna

2025-10-23 10:29:00 Annexin's Q3: Establishment of Medical Advisory Board and focus on ophthalmology

2025-10-23 10:29:00 Annexins Q3: Etablering av Medical Advisory Board och fokus på oftalmologi

2025-10-20 16:32:00 BioInvents onkolytiska virus presenterat på ESMO

2025-10-20 16:32:00 BioInvent’s oncolytic virus showcased at ESMO

2025-10-20 10:23:00 Alzinova secures short-term financing – CEO comments

2025-10-20 10:23:00 Alzinova säkrar kortsiktig finansiering – vd kommenterar

2025-10-16 09:24:00 Spago’s CEO comments on Proof-of-Concept milestone

2025-10-15 10:45:00 PHI comments on expansion into veterinary IVF

2025-10-15 10:45:00 PHI kommenterar expansionen till veterinärmedicinsk IVF

2025-10-15 09:17:00 Enzymatica launches new ColdZyme flavour

2025-10-15 09:17:00 Enzymatica lanserar ny smak av ColdZyme

2025-10-14 11:33:00 BioInvent comments on the new chapter for BI-1206

2025-10-14 11:33:00 BioInvent kommenterar nästa kapitel för BI-1206

2025-10-13 10:20:00 UCLA study provides OncoZenge with patient insights ahead of phase III

2025-10-13 10:20:00 UCLA-studie ger OncoZenge patientperspektiv inför fas III-start

2025-10-10 13:00:00 SynAct Pharma's CBO: “We are pioneering the future of inflammation care”

2025-10-10 13:00:00 SynAct Pharma’s CBO: “We are pioneering the future of inflammation care”

2025-10-10 12:16:00 Screening kan ändra spelplanen för typ 1-diabetes

2025-10-10 12:16:00 Screening - a potential game changer for type 1 diabetes

2025-10-08 08:05:00 SynAct Pharma: "We're on track and on time"

2025-10-08 08:05:00 SynAct Pharma:"We're on track and on time"

2025-10-07 13:27:00 Cantargia:”Our data is very compelling”

2025-10-07 13:27:00 Cantargia: ”Our data is very compelling”

2025-10-07 10:01:00 Alzinova comments on the FDA Fast Track Designation

2025-10-07 10:01:00 Alzinova kommenterar Fast Track från FDA

2025-10-07 09:19:00 Carbiotix: ”We are trailblazers”

2025-10-07 09:19:00 Carbiotix:”We are trailblazers”

2025-10-07 09:07:00 Lipum gears up with new CFO – one month into the assignment

2025-10-07 09:07:00 Lipum växlar upp med ny CFO – en månad in i uppdraget

2025-10-06 14:11:00 BioStock: PILA PHARMA partners with Gubra for preclinical obesity trials

2025-10-06 09:55:00 BioStock: PILA PHARMA inleder samarbete med Gubra för prekliniska obesitasstudier

2025-10-06 09:15:00 Qlife and Hipro extend deadline for merger

2025-10-06 09:15:00 Qlife och Hipro förlänger deadline för fusionen

2025-10-03 11:41:00 Curasight reinforces the value of uTRACE with new US patent

2025-10-03 11:41:00 Curasight stärker värdet av uTRACE med nytt amerikanskt patent

2025-10-01 12:07:00 Green light for higher doses in Isofol’s arfolitixorin study

2025-10-01 12:07:00 Klartecken för högre doser i Isofols arfolitixorin-studie

2025-10-01 10:02:00 PHI gears up for next-gen launch after strong year

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

BioStock

Prenumeration

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden